Company / Current Liabilities per Share
Vertex Pharmaceuticals Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$15.03
FY2025
5-year range
$8.24 / $15.03
FY2021-FY2025
Trend
+8.6%
vs FY2024
Sector context
#11 of 210
Health Care
What the data says
Among 210 Health Care companies, Vertex Pharmaceuticals is in the bottom 5% for current liabilities per share. Current Liabilities per Share has increased for 9 consecutive years, from $3.22 in FY2016 to $15.03 in FY2025.
Based on SEC 10-K filings.
15.03 in FY2025 with a 5-year CAGR of +15.7%. Top quartile in the Health Care sector.
Increased from $13.80 to $15.03 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +11.7%
- 5-Year CAGR
- +15.7%
- 10-Year CAGR
- -
Sector benchmark
-36.8% below sector average
Key checks
Key Insights
- Vertex Pharmaceuticals's current liabilities per share has grown for 9 consecutive years.
- In FY2025, current liabilities per share increased 8.6% year-over-year.
- Ranks #11 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.03 | +8.6% |
| FY2024 | $13.83 | +0.2% |
| FY2023 | $13.80 | +28.1% |
| FY2022 | $10.78 | +30.7% |
| FY2021 | $8.24 | +13.7% |
| FY2020 | $7.25 | +38.6% |
| FY2019 | $5.23 | +18.3% |
| FY2018 | $4.42 | +36.1% |
| FY2017 | $3.25 | +1.0% |
| FY2016 | $3.22 | +53.7% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026